Cynim-P Tablet

Introduction

Cynim-P is a prescription medication that contains two active ingredients: Nimesulide and Paracetamol. It is commonly used to relieve pain and reduce inflammation. This medication is available under the brand name Cynim-P.

Uses

Cynim-P is primarily prescribed for the treatment of various conditions, including pain, fever, and inflammation. It can be used to alleviate mild to moderate pain associated with conditions such as headaches, toothaches, menstrual cramps, and musculoskeletal injuries. It also helps to reduce fever and inflammation caused by various infections and injuries.

Dosage and Administration

Cynim-P should be taken as directed by your healthcare provider. The dosage may vary depending on the severity of your symptoms and your medical condition. Follow the prescribed dosage instructions carefully.

Typically, the recommended dose for adults is one tablet taken orally, with or without food. Swallow the tablet whole with a full glass of water. Do not crush or chew the tablet unless your healthcare provider advises otherwise.

If you are using Cynim-P for a child, the dosage will be based on their age and weight. Consult your healthcare provider for the appropriate dosage for children.

Mechanism of Action

Cynim-P contains two active ingredients: Nimesulide and Paracetamol.

Nimesulide belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the production of certain chemicals in the body that cause pain, inflammation, and fever. By reducing the levels of these chemicals, Nimesulide helps to relieve pain and reduce inflammation.

Paracetamol is an analgesic and antipyretic medication. It works by blocking the production of certain chemicals in the brain that cause pain and fever. Paracetamol helps to relieve pain and reduce fever.

Side Effects

Cynim-P may cause some side effects in certain individuals. These side effects can vary in severity and may include:

• Common side effects: These may include nausea, vomiting, stomach pain, indigestion, dizziness, and headache. These side effects are usually mild and temporary.
• Serious side effects: Although rare, some individuals may experience serious side effects such as allergic reactions, difficulty breathing, skin rashes, liver problems, and gastrointestinal bleeding. If you experience any of these serious side effects, seek immediate medical attention.

If you have any concerns about the side effects of Cynim-P, consult your healthcare provider for further guidance.

Drug Interactions

Cynim-P may interact with certain medications, which can affect how it works or increase the risk of side effects. Inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements.

Some common drug interactions with Cynim-P may include:

• Warfarin and other blood thinners
• Methotrexate
• Lithium
• ACE inhibitors and angiotensin receptor blockers (ARBs)
• Diuretics (water pills)
• Other NSAIDs

To minimize the risk of drug interactions, your healthcare provider will carefully consider your medical history and current medications before prescribing Cynim-P.

Precautions

Before taking Cynim-P, take certain precautions to ensure your safety and the effectiveness of the medication.

• Contraindications: Cynim-P should not be used in individuals who have a known hypersensitivity to Nimesulide, Paracetamol, or any other ingredient present in the medication. It should also be avoided in patients with a history of asthma, gastrointestinal bleeding, kidney or liver problems, and certain blood disorders.
• Interactions with other medications or substances: Cynim-P may interact with alcohol, increasing the risk of liver damage. Avoid alcohol while taking this medication. Additionally, it may interact with certain medications, as mentioned in the previous section on drug interactions.

Discuss your medical history, including any allergies or underlying health conditions, with your healthcare provider before starting Cynim-P.

Storage

Cynim-P should be stored at room temperature, away from moisture and heat. Keep it in a secure place, out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take the medication exactly as prescribed by your healthcare provider. Do not exceed the recommended dosage or use it for longer than necessary.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule.
• If you accidentally take more than the prescribed dose, seek immediate medical attention, even if you do not feel any different.
• Do not combine Cynim-P with other medications containing Nimesulide, Paracetamol, or other NSAIDs, unless specifically advised by your healthcare provider.
• If you experience any new or worsening symptoms while taking Cynim-P, such as persistent stomach pain, black stools, or yellowing of the skin or eyes, contact your healthcare provider immediately.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Paracetamol for adults: painkiller for pain and high temperature (NHS UK) [Accessed 17 Jun. 2024] (online) Available at:
• Alka-Seltzer XS (Health Professionals SmPC) Available at:
• What is Nimesulide used for? (Drugs.com) [Accessed 29 Jun. 2024] (online) Available at:
• paracetamol tablet (OTC) [Accessed 9 Jun. 2024] (online) Available at:
• LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases) [Accessed 14 Jun. 2024] (online) Available at:
• Pulkkinen M. Nimesulide in dysmenorrhoea. Drugs. 1993;46 Suppl 1:129-33. doi: 10.2165/00003495-199300461-00028. [Accessed 12 Jun. 2024] Available at: